Nov 15, 2024 · A photobiomodulation therapy device has received approval by the US Food and Drug Administration (FDA) to be marketed for the treatment of nonexudative (dry) age-related macular degeneration (AMD), according to statements from the FDA and the manufacturer.The device allows physicians the opportunity to offer a noninvasive treatment for dry AMD with a low-level laser therapy (LLLT) technology. 1,2

Dec 17, 2024 · Systemic methotrexate and azathioprine therapies are associated with a lower risk of proliferative vitreoretinopathy (PVR) development within 6 months of primary retinal detachment, according to the results of a multicenter retrospective cohort study published in Ophthalmology Retina.. PVR is a predominant cause of failure for repair of retinal detachment.

Dec 4, 2024 · The Food and Drug Administration (FDA) has approved a generic latanoprost, a prostaglandin analogue, for the treatment of open-angle glaucoma and ocular hypertension, according to a pharmaceutical manufacturer’s press release.The announcement from Gland Pharma Limited says that the FDA has found the generic latanoprost both bioequivalent and therapeutically equivalent to Xalatan ...

Jun 24, 2022 · Tori Rodriguez, MA, LPC, AHC, is an Atlanta-based journalist, licensed psychotherapist, and Ayurvedic health coach, creator of the body-positive wellness company Bettie Page Fitness, and author of 2 books – The Little Book of Bettie: Taking a Page from the Queen of Pinups and Bettie Page: The Lost Years.

Nov 15, 2024 · The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA) and making a final decision on marketing approval. The typical period for review is 10 months after the drug application has been accepted by the Agency.

Oct 28, 2024 · A novel lipid-containing eye drop is noninferior to a commercially available nonlipid comparator in all dry eye parameters measured, according to research published in BMC Ophthalmology.The medication reviewed, (Blink ® Triple Care [BTC], Bausch+Lomb, Inc.) may serve as an effective alternative therapy for patients with dry eye symptoms who would benefit from a lipid-based artificial tear ...

Jul 20, 2023 · Myasthenia gravis (MG) can occur in 2 forms: a generalized myasthenia gravis (GMG) or purely ocular myasthenia gravis (OMG). Ocular myasthenia gravis is characterized by progressive fatigability of skeletal muscle limited to the orbicularis oculi, levator palpebrae superioris, and the extraocular muscles. 1 Up to half of patients diagnosed with MG present with ocular muscle weakness before ...

Nov 10, 2024 · The study analyzed medical records of 940,763 individuals and found that ADHD was more prevalent among people with keratoconus compared with among the whole cohort (0.24% vs 0.16%). 7 The study also shows that people with keratoconus are approximately 1.6 times more likely to be diagnosed with ADHD.

Dec 4, 2024 · The table below is a review of notable updates that occurred in November 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. The table below is a review of notable updates that occurred in November 2024 for investigational products in development.

Nov 20, 2023 · Preservative-free sodium hyaluronate (0.4%) eye drops in different dosages effectively alleviates signs and symptoms of dye eye disease (DED) after 1 month of treatment in approximately 50% of patients, according to a study published in Clinical Ophthalmology.. Researchers investigated the effectiveness of the preservative-free sodium hyaluronate drops in a randomized, parallel assignment ...